Prudential Financial Inc. raised its stake in Cigna Corporation (NYSE:CI) by 76.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 620,301 shares of the health services provider’s stock after buying an additional 268,440 shares during the period. Prudential Financial Inc. owned about 0.24% of Cigna Corporation worth $103,832,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. State of Alaska Department of Revenue acquired a new stake in Cigna Corporation during the first quarter valued at approximately $689,000. Candriam Luxembourg S.C.A. raised its stake in Cigna Corporation by 20.3% in the first quarter. Candriam Luxembourg S.C.A. now owns 15,839 shares of the health services provider’s stock valued at $2,320,000 after buying an additional 2,672 shares during the last quarter. First Manhattan Co. raised its stake in Cigna Corporation by 4.5% in the first quarter. First Manhattan Co. now owns 9,910 shares of the health services provider’s stock valued at $1,291,000 after buying an additional 424 shares during the last quarter. Profund Advisors LLC raised its stake in Cigna Corporation by 8.3% in the first quarter. Profund Advisors LLC now owns 10,359 shares of the health services provider’s stock valued at $1,517,000 after buying an additional 795 shares during the last quarter. Finally, ProShare Advisors LLC raised its stake in Cigna Corporation by 1.6% in the first quarter. ProShare Advisors LLC now owns 25,930 shares of the health services provider’s stock valued at $3,798,000 after buying an additional 405 shares during the last quarter. 87.61% of the stock is currently owned by institutional investors and hedge funds.

Cigna Corporation (NYSE CI) opened at 179.30 on Friday. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $181.15. The stock’s 50 day moving average is $175.07 and its 200 day moving average is $161.41. The stock has a market capitalization of $45.14 billion, a PE ratio of 20.69 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.98 earnings per share. Equities analysts anticipate that Cigna Corporation will post $10.03 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Prudential Financial Inc. Increases Stake in Cigna Corporation (CI)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.thecerbatgem.com/2017/08/26/prudential-financial-inc-increases-stake-in-cigna-corporation-ci.html.

CI has been the topic of several research reports. Stifel Nicolaus boosted their price objective on shares of Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, May 5th. Jefferies Group LLC reissued a “buy” rating and set a $183.00 price objective (up previously from $178.00) on shares of Cigna Corporation in a research note on Friday, May 5th. Royal Bank Of Canada boosted their price objective on shares of Cigna Corporation from $172.00 to $177.00 and gave the stock an “outperform” rating in a research note on Monday, May 8th. Deutsche Bank AG boosted their price objective on shares of Cigna Corporation from $172.00 to $175.00 and gave the stock a “buy” rating in a research note on Wednesday, May 10th. Finally, Cowen and Company reissued an “outperform” rating and set a $185.00 price objective (up previously from $160.00) on shares of Cigna Corporation in a research note on Thursday, June 1st. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $180.44.

In other news, VP Mary T. Hoeltzel sold 500 shares of the stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total value of $83,350.00. Following the completion of the sale, the vice president now directly owns 2,449 shares of the company’s stock, valued at $408,248.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David Cordani sold 153,168 shares of the stock in a transaction that occurred on Monday, June 19th. The shares were sold at an average price of $170.20, for a total value of $26,069,193.60. Following the completion of the sale, the chief executive officer now directly owns 421,162 shares of the company’s stock, valued at $71,681,772.40. The disclosure for this sale can be found here. Insiders sold 232,008 shares of company stock valued at $39,828,200 over the last three months. Corporate insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.